First Time Loading...

Neurotech International Ltd
ASX:NTI

Watchlist Manager
Neurotech International Ltd Logo
Neurotech International Ltd
ASX:NTI
Watchlist
Price: 0.078 AUD 4% Market Closed
Updated: May 16, 2024

Neurotech International Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neurotech International Ltd
Revenue Peer Comparison

Comparables:
IPD
C
CYC
COH
OIL
EMV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Neurotech International Ltd
ASX:NTI
Revenue
AU$1.3m
CAGR 3-Years
160%
CAGR 5-Years
39%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Revenue
AU$10.5m
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
13%
C
Cyclopharm Ltd
ASX:CYC
Revenue
AU$27.8m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
9%
Cochlear Ltd
ASX:COH
Revenue
AU$2.1B
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
11%
Optiscan Imaging Ltd
ASX:OIL
Revenue
AU$1.7m
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
34%
EMvision Medical Devices Ltd
ASX:EMV
Revenue
AU$7.1m
CAGR 3-Years
93%
CAGR 5-Years
70%
CAGR 10-Years
N/A

See Also

What is Neurotech International Ltd's Revenue?
Revenue
1.3m AUD

Based on the financial report for Dec 31, 2023, Neurotech International Ltd's Revenue amounts to 1.3m AUD.

What is Neurotech International Ltd's Revenue growth rate?
Revenue CAGR 5Y
39%

Over the last year, the Revenue growth was 204%. The average annual Revenue growth rates for Neurotech International Ltd have been 160% over the past three years , 39% over the past five years .